Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
34.24    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.44 (4.253%)
Market Cap: £547.50m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Board Changes

16 Jan 2025 07:00

RNS Number : 4829T
Hays PLC
16 January 2025
 

16 January 2025

 

HAYS PLC

BOARD CHANGES

Hays plc ("Hays") today announces the appointment of Michael Findlay to its Board as a Non-Executive Director and Chair-designate. He will join the Board on 20 January 2025 and will succeed Andrew Martin as Non-Executive Chair from 1 May 2025. Andrew will retire on 1 May 2025 after nearly 8 years on the Board.

Michael Findlay is currently Non-Executive Chair of London Stock Exchange plc and a Non-Executive Director of International Distribution Services plc and Jarrold & Sons Limited. Michael is also Chair of Morgan Sindall Group plc but announced yesterday that he will be stepping down from the Board on 28 July 2025. Previous roles include co-head of investment banking for UK and Ireland at Bank of America and Senior Independent Director at UK Mail Group plc.

Cheryl Millington, Hays' Senior Independent Director, who led the succession process, said: "I am delighted that Michael will be joining the Hays Board. Michael is a highly accomplished business leader and a proven Non-Executive and Chair. Having spent his executive career in corporate broking and investment banking, Michael has advised many leading UK plcs on a wide range of strategic, financing and governance matters. He also brings a strong understanding of people intensive and service orientated businesses."

"I also want to take this opportunity to thank Andy on behalf of the Board for his exemplary leadership, during a period of significant change for the Group, and wish him all the very best for the future."

Michael said: "I am delighted to be joining Hays and I look forward to working with the Board and the executive team to drive forward the Group's strategy to create significant value for all stakeholders."

Andy Martin commented: "It has been a privilege to serve on the Board of Hays for nearly 8 years. It is a great company and I wish all of the incredible team every success for the future, and wish Michael all the very best as he leads the Board on this next important step of the Hays journey."

This announcement is made in accordance with Listing Rule 6.4.6. There are no further matters to be disclosed under Listing Rule 6.4.8.

 

Enquiries

Hays plc

Rachel FordKean Marden

FGS GlobalGuy Lamming / Anjali Unnikrishnan / Richard Crowley

 

General Counsel & Company Secretary

Head of Investor Relations & ESG

 

+44 (0) 333 010 2682

+44 (0) 333 010 7092hays@fgsglobal.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVANRVAUAAAR
Date   Source Headline
20th Sep 20225:28 pmRNSTransaction in Own Shares
16th Sep 20225:39 pmRNSTransaction in Own Shares
15th Sep 20221:40 pmRNSDirector/PDMR Shareholding
13th Sep 202212:25 pmRNSDirector/PDMR Shareholding
7th Sep 20221:40 pmRNSDirector/PDMR Shareholding
5th Sep 20225:46 pmRNSTransaction in Own Shares
2nd Sep 20225:52 pmRNSTransaction in Own Shares
2nd Sep 202212:19 pmRNSDirector/PDMR Shareholding
1st Sep 20225:30 pmRNSTransaction in Own Shares
1st Sep 202212:17 pmRNSTotal Voting Rights
30th Aug 20225:30 pmRNSTransaction in Own Shares
26th Aug 20225:31 pmRNSTransaction in Own Shares
26th Aug 20227:53 amRNSDirector/PDMR Shareholding
25th Aug 20225:36 pmRNSTransaction in Own Shares
25th Aug 20227:00 amRNSFinal Results
24th Aug 20225:28 pmRNSTransaction in Own Shares
24th Aug 20227:00 amRNSTransaction in Own Shares
22nd Aug 20225:42 pmRNSTransaction in Own Shares
19th Aug 20225:06 pmRNSTransaction in Own Shares
18th Aug 20225:35 pmRNSTransaction in Own Shares
18th Aug 202212:08 pmRNSHolding(s) in Company
17th Aug 20225:30 pmRNSTransaction in Own Shares
17th Aug 20227:00 amRNSTransaction in Own Shares
15th Aug 20225:50 pmRNSTransaction in Own Shares
12th Aug 20225:13 pmRNSTransaction in Own Shares
11th Aug 20225:32 pmRNSTransaction in Own Shares
10th Aug 20225:12 pmRNSTransaction in Own Shares
9th Aug 20225:37 pmRNSTransaction in Own Shares
8th Aug 20225:14 pmRNSTransaction in Own Shares
5th Aug 20225:22 pmRNSTransaction in Own Shares
3rd Aug 20225:35 pmRNSTransaction in Own Shares
2nd Aug 20225:31 pmRNSTransaction in Own Shares
1st Aug 20225:01 pmRNSTotal Voting Rights
1st Aug 202212:10 pmRNSBlock listing Interim Review
28th Jul 20225:19 pmRNSTransaction in Own Shares
27th Jul 20225:34 pmRNSTransaction in Own Shares
26th Jul 20225:58 pmRNSTransaction in Own Shares
25th Jul 20225:27 pmRNSTransaction in Own Shares
14th Jul 20227:00 amRNSFourth Quarter Trading Update
13th Jul 20225:21 pmRNSTransaction in Own Shares
12th Jul 20225:11 pmRNSTransaction in Own Shares
11th Jul 20225:48 pmRNSTransaction in Own Shares
11th Jul 202212:38 pmRNSTotal Voting Rights: Replacement
6th Jul 20227:00 amRNSTransaction in Own Shares
4th Jul 20226:06 pmRNSTransaction in Own Shares
1st Jul 20225:32 pmRNSTransaction in Own Shares
1st Jul 202210:02 amRNSTotal Voting Rights
30th Jun 20226:09 pmRNSTransaction in Own Shares
29th Jun 20225:44 pmRNSTransaction in Own Shares
29th Jun 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.